【レポートの概要(一部)】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 9
2 Pharmaceuticals & Healthcare, Global, Deal Summary 12
2.1 Pharmaceuticals & Healthcare, Global, Deal Analysis, August 2013 12
2.2 Pharmaceuticals & Healthcare, Global, Major Deals, August 2013 14
2.2.1 Amgen Receives Antitrust Approval to Acquire Onyx Pharma for up to US$10.4 Billion 14
2.2.2 Celgene Completes Public Offering of Notes for US$1.5 Billion 15
2.2.3 Sanofi Prices Public Offering of Bonds Due 2020 for US$1.3 Billion 16
2.2.4 Akorn to Acquire Hi-Tech Pharmacal for US$640 Million 16
2.2.5 Pharmstandard Completes Acquisition of Bever Pharma for US$590 Million 17
2.3 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, August 2013 18
2.4 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, August 2013 19
3 Pharmaceuticals and Healthcare, Global, Deals, Summary, by Type 20
3.1 Pharmaceuticals & Healthcare, Global, M&A, August 2013 20
3.1.1 Top M&A Deals in August 2013 21
3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals by Therapy Area, March 2013 – August 2013 22
3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, August 2013 24
3.2.1 Top Equity Offering Deals in August 2013 26
3.2.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, March 2013 – August 2013 27
3.3 Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital Deals, August 2013 29
3.3.1 Top PE/VC Deals in August 2013 30
3.3.2 Pharmaceuticals & Healthcare, Global, PE/VC by Therapy Area, August 2013 31
3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, August 2013 33
3.3.4 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, March 2013-August 2013 35
3.3.5 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, March 2013-August 2013 36
4 Pharmaceuticals & Healthcare, Global, Partnership Deals, August 2013 37
4.1 Pharmaceuticals & Healthcare, Global, Partnership Deals, August 2013 37
4.2 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, March 2013 – August 2013 39
4.3 Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payments and Deal Values (US$ m), August 2013 41
4.3.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals by Payment Mode, August 2013 42
4.4 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), March 2013 – August 2013 43
4.5 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Number Of Deals, March 2013 – August 2013 45
4.6 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Deal Values (US$ m), March 2013 – August 2013 46
4.7 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), March 2013 – August 2013 48
5 Pharmaceuticals & Healthcare, Global, Licensing Agreements, August 2013 50
5.1 Pharmaceuticals & Healthcare, Global, Licensing Agreements, August 2013 50
5.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), August 2013 52
5.2.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Deal Value, August 2013 54
5.2.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, August 2013 54
5.2.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Total Milestone Payment, August 2013 54
5.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Total Deal Values (US$ m), March 2013 – August 2013 55
5.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront Payments and Milestone Payments (US$ m), March 2013 – August 2013 57
5.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Total Deal Values (US$ m), March 2013 – August 2013 59
5.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Upfront Payments and Milestone Payments (US$ m), March 2013 – August 2013 61
6 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area 63
6.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, August 2013 63
6.1.1 Oncology – Deals of the Month 65
6.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, August 2013 67
6.2.1 Central Nervous System – Deals of the Month 68
6.3 Pharmaceuticals & Healthcare, Global, Immunology Deals, August 2013 70
6.3.1 Immunology – Deal of the Month 71
6.4 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, August 2013 72
6.4.1 Infectious Diseases – Deals of the Month 74
6.5 Pharmaceuticals & Healthcare, Global, Metabolic Disorder Deals, August 2013 75
6.5.1 Metabolic Disorders – Deal of the Month 76
6.6 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, August 2013 77
6.6.1 Cardiovascular – Deal of the Month 78
6.7 Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals, August 2013 79
6.7.1 Gastrointestinal – Deal of the Month 80
7 Deal Summary by Geography 81
7.1 Pharmaceuticals & Healthcare, North America Deals, August 2013 81
7.1.1 North America – Deals of the Month 82
7.2 Pharmaceuticals & Healthcare, Europe, Deals, August 2013 84
7.2.1 Europe – Deals of the Month 85
7.3 Pharmaceuticals & Healthcare, Asia-Pacific, Regional Deals, August 2013 87
7.3.1 Asia-Pacific – Deals of the Month 88
7.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, August 2013 90
7.4.1 Rest of the World – Deals of the Month 91
8 Pharmaceuticals & Healthcare, Global, Top Financial Advisors 92
8.1 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, March 2013 – August 2013 92
8.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, March 2013 – August 2013 94
9 Further Information 96
9.1 Methodology 96
9.2 About GlobalData 97
9.3 Disclosure information 98
9.4 Disclaimer 98
【レポート販売概要】
■ タイトル:事業提携・ライセンシング・投資・M&A動向:August 2013(製薬業界)■ 英文:Partnerships, Licensing, Investments and M&A Deals and Trends for August 2013 in Pharmaceuticals
■ 発行日:2013年9月30日
■ 調査会社:GlobalData
■ 商品コード:GDATA403162245
■ 調査対象地域:グローバル
- 2014年戦略提言:世界の潜血検査市場The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technolog …
- インストアアナリティクスの世界市場2019-2023Global In-store Analytics Market: About this market Technavio’s in-store analytics market analysis considers sales from customer management, merchandising analysis, in-store operations, supply chain management, strategy, and planning. Our analysis also considers the sales of in-store analytics in APAC, Europe, North America, South America, and MEA. In 2018, the customer management segment had a si …
- 世界の交通管理市場:ソリューション、ディスプレイ、システムThe traffic management report consists of market opportunity, analysis of technology adoption in systems, solutions, detections, and displays market. The report explores some of the major sub-segments of solutions market: Extra Low Voltage (ELV) solutions, intersection controllers, full pedestrian solutions, LED signals retrofit solutions and parking space and ticketing management solutions; detec …
- 電子臨床成果評価(eCOA)ソリューションの世界市場分析:送達モード別(Webホスト、ライセンス企業、クラウドベース)、エンドユーザー別(病院、CRO、学術機関、バイオ製薬団体)、セグメント予測、2014-2025The global electronic clinical outcome assessment (eCOA) solutions market is expected to reach USD 2.16 billion by 2025, according to a new report by Grand View Research, Inc. The complexity in healthcare information management is anticipated to fuel the demand for eCOA solutions in coming years. These solutions deliver accurate and timely health information and reduce burden of patients enrolled …
- 世界における企業向けネットワーク料金の情報サービス(年間購読)TeleGeography’s Enterprise Network Pricing Service is a detailed and up-to-date source of pricing data and expert analysis of pricing trends for international IP VPN, retail private line, and Dedicated Internet Access (DIA) services. Prices reflect competitive bid or discounted list prices.
- 線材加工機の世界市場ABSTRACTAbout Wire Processing Machines The global market for wires and cables has witnessed a significant growth rate over the past few years, which in turn has influenced the wire processing machines market globally. The demand for these wires and cables is majorly driven by automotive and aerospace industries. These industries use an assembly of wires that transmits electrical signals; in additi …
- 世界のクラウドコンピューティング市場:インフラ、プラットフォーム、サービスCloud is an enabler of business process change as it facilitates enterprise to realize key benefits including expenditure reduction (CapEx and OpEx), service development and delivery efficiencies, and greater flexibility to meet evolving business needs. Cloud technologies and solutions are also becoming more important to telecommunications service providers as they begin to implement virtualizatio …
- 世界の調味料、ドレッシング及びソース市場のニュース及びイベント動向(2014年6月)Synopsis The report provides a review of the latest news and key events in the global seasonings, dressings & sauces market during June 2014. Summary Using this report, marketers will effectively gain an insight into the latest happenings in the global seasonings, dressings & sauces market throughout the month. The monthly report provides the reader with the top-line data necessary to quickly keep …
- スプライシングテープの世界市場2019-2023Global Splicing Tapes Market: About this market Splicing tapes are adhesive tapes with single or double layers of the adhesive coating. Technavio’s splicing tapes market analysis considers sales from acrylic, rubber, silicone, and others. Our analysis also considers the sales of splicing tapes in APAC, Europe, North America, South America, and MEA. In 2018, the acrylic segment had a significant ma …
- 運動失調(Ataxia):グローバル臨床試験レビュー(2014年上半期)Ataxia Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Ataxia Global Clinical Trials Review, H1, 2014" provides data on the Ataxia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ataxia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction ac …
- 世界におけるアレルギー血液検査デバイスの製品パイプライン動向2015Allergy Blood Tests - Pipeline Review, 2015 Summary GlobalData's Medical Devices sector report, “Allergy Blood Tests - Pipeline Review, 2015" provides an overview of Allergy Blood Tests currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players invol …
- 合成ゼオライトの世界市場予測(~2023年)“Increasing demand for synthetic zeolites for use in specialty applications is expected to drive the overall growth of synthetic zeolites market.”The synthetic zeolites market is projected to grow from USD 5.2 billion in 2018 to USD 5.9 billion by 2023 at a Compound Annual Growth Rate (CAGR) of 2.6% during the forecast period. The growth of the synthetic zeolites market can be attributed to the in …
- 分子診断の世界市場分析:製品別、テストロケーション別(Poc、中央検査室)、技術別(PCR、原位置ハイブリダイゼーション、INAAT、マイクロアレイ、MS、NGS、TMA))、用途別(腫瘍、乳がん、前立腺がん、子宮頸がん、薬理ゲノム学、感染症、MRSA、C。ディフィシル、バンコマイシン耐性腸球菌、カルバペネム耐性、インフルエンザ、RSV、カンジダ、結核、髄膜炎、GITテスト、クラミジア、淋病、HIV、HCV、HBV 、遺伝学、神経学、心臓血管)、セグメント予測Global molecular diagnostics market is expected to reach over USD 17.9 billion by 2024, based on a new report by Grand View Research, Inc. Increasing prevalence of infectious diseases including human papillomavirus and influenza is expected to be the primary driving force for the growth of the molecular diagnostics market. In the underdeveloped regions of Africa and Nigeria, other infections, such …
- 世界の殺菌製品及びサービス市場(医療産業)動向(2014~2018)TechNavio's analysts forecast the Global Sterilization Products and Services market to grow at a CAGR of 6.34 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing prevalence of hospital-acquired infection. The Global Sterilization Products and Services market has also been witnessing the increase in contract sterilization services. However, …
- 虹彩認証の世界市場2016-2020About Iris Recognition Iris recognition is one of the most secure, and accurate biometrics modality that is used for security and surveillance purposes in sectors such as government, military and defense, healthcare, banking and finance, consumer electronics, travel and immigration, and automotive. This biometrics technology came into existence in 1994 and many countries across the globe have depl …